Eurofins, FR0014000MR3

Eurofins stock holds firm as CAC 40 slips, investors eye dividend and growth

Published on 09/20/2026 at 17:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Eurofins stock was the only CAC 40 constituent to rise on September 20, 2026, gaining 0.19 percent while the French benchmark fell 1.70 percent. The laboratory group reported revenue of EUR 7.30 billion in fiscal year 2025 and offers a 4.75 percent dividend yield.

Wissenschaftlerin analysiert Lebensmittelproben mit Pipette im modernen Testlabor
Fotorealistisches Labor mit Pipetten zeigt Eurofins Scientific SE, den Prüfdienstleister mit ISIN FR0014000MR3, bei Probenanalyse, Illustration mit AI erstellt.

Eurofins Scientific stock (ISIN FR0014000MR3) stood out among French blue chips on September 20, 2026, as the shares gained 0.19 percent while the CAC 40 index fell 1.70 percent, making Eurofins the only constituent in positive territory that day according to ANTARA News Ambon.

Eurofins stock edges higher against a weak French market

As ANTARA News Ambon reported on September 20, 2026, the CAC 40 index closed down 1.70 percent, yet Eurofins Scientific S.E. shares rose 0.19 percent, highlighting the stock's relative resilience compared with the broader French equity market.

This divergence means that on that trading day Eurofins stock outperformed the index by 1.89 percentage points, a small but notable cushion for investors watching French blue chips under pressure.

Dividend yield and past revenue growth support the investment case

Eurofins Scientific S.E. combines laboratory testing services for pharmaceutical, food, environmental, agriscience and consumer product industries, and its cash distributions are relevant for income-focused investors. According to DivvyDiary, Eurofins Scientific S.E. offers a dividend yield of 4.75 percent in September 2026, positioning the stock as a relatively high-yielding play in the European laboratory and testing sector.

For investors assessing the growth backdrop, job information from Indeed notes that Eurofins achieved total revenue of EUR 7.296 billion in fiscal year 2025, underscoring its scale as one of Europe's better-performing stocks over the last two decades in terms of share price appreciation.

Historically, that fiscal year 2025 revenue level shows how far the group has expanded from its earlier footprint, and the current dividend yield of 4.75 percent offers investors a cash return that can complement any future revenue or earnings growth.

Stock price level and investor perspective

On the primary listing at Euronext Paris, Eurofins stock recently traded at a level that produced the 0.19 percent gain on September 20, 2026, compared with the prior close, while the CAC 40 slid 1.70 percent according to ANTARA News Ambon.

Eurofins Scientific stock facts

  • Company: Eurofins Scientific S.E.
  • ISIN: FR0014000MR3
  • Ticker: ERF
  • Trading venue: Euronext Paris
  • Sector / Industry: Health care, laboratory testing and diagnostics
  • Index membership: CAC 40

More news and analyses on Eurofins Scientific stock

Disclaimer...

en | FR0014000MR3 | EUROFINS | boerse | 70138455 | bgmi